State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization /
Saved in:
| Imprint: | Washington, DC : American Chemical Society, 2015. |
|---|---|
| Description: | 1 online resource (439 pages) : illustrations (some color). |
| Language: | English |
| Series: | ACS symposium series, 1947-5918 ; 1201 ACS symposium series ; 1201. |
| Subject: | |
| Format: | E-Resource Book |
| Local Note: | American Chemical Society, ACS Symposium Series eBooks - 2015 Front Files. |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/12570547 |
MARC
| LEADER | 00000nam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | 12570547 | ||
| 006 | m fo d | ||
| 007 | cr cn nnnauuuu | ||
| 008 | 190122s2015 dcua ob 101 0 eng d | ||
| 003 | ICU | ||
| 020 | |a 9780841230309 |q electronic | ||
| 024 | 8 | |a bk-2015-1201 | |
| 035 | |a (ACS)ccn00867284 | ||
| 040 | |a NjRocCCS |b eng |e rda |c NjRocCCS | ||
| 050 | 4 | |a QR186.85 |b .S73 2014 | |
| 060 | 4 | |a QW 575.5.A6 |b S797 2015 | |
| 082 | 0 | 4 | |a 616.07/98 |2 23 |
| 084 | |a MED052000 |a MED044000 |2 bisacsh | ||
| 245 | 0 | 0 | |a State-of-the-art and emerging technologies for therapeutic monoclonal antibody characterization / |c John E. Schiel, editor, National Institute of Standards and Technology, Gaithersburg, Maryland, Darryl L. Davis, editor, Janssen Research and Development, LLC, Spring House, Pennsylvania, Oleg V. Borisov, editor, Novavax, Inc., Gaithersburg, Maryland. |
| 264 | 1 | |a Washington, DC : |b American Chemical Society, |c 2015. | |
| 300 | |a 1 online resource (439 pages) : |b illustrations (some color). | ||
| 336 | |a text |2 rdacontent |0 http://id.loc.gov/vocabulary/contentTypes/txt | ||
| 337 | |a computer |2 rdamedia |0 http://id.loc.gov/vocabulary/mediaTypes/c | ||
| 338 | |a online resource |2 rdacarrier |0 http://id.loc.gov/vocabulary/carriers/cr | ||
| 490 | 1 | |a ACS symposium series, |x 1947-5918 ; |v 1201 | |
| 500 | |a Distributed in print by Oxford University Press. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 505 | 0 | 0 | |t Determination of the NISTmAb Primary Structure / |r Formolo, Trina, Biomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States; Ly, Mellisa, Mass Spectrometry and Biophysical Characterization, Analytical Research and Development, BioTherapeutics Pharmaceutical Sciences, Pfizer, Inc., Andover, Massachusetts 01810, United States; Levy, Michaella, Center for Drug Evaluation and Research, Office of Testing and Research, Division of Pharmaceutical Analysis, U.S. Food and Drug Administration, Saint Louis, Missouri 63110, United States; Kilpatrick, Lisa, Biomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States; Lute, Scott, Center for Drug Evaluation and Research, Office of Biotechnology Products, Division of Monoclonal Antibodies, U.S Food and Drug Administration, Silver Spring, Maryland 20993, United States; Phinney, Karen, Biomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States; Marzilli, Lisa, Mass Spectrometry and Biophysical Characterization, Analytical Research and Development, BioTherapeutics Pharmaceutical Sciences, Pfizer, Inc., Andover, Massachusetts 01810, United States; Brorson, Kurt, Center for Drug Evaluation and Research, Office of Biotechnology Products, Division of Monoclonal Antibodies, U.S Food and Drug Administration, Silver Spring, Maryland 20993, United States; Boyne, Michael, Center for Drug Evaluation and Research, Office of Testing and Research, Division of Pharmaceutical Analysis, U.S. Food and Drug Administration, Saint Louis, Missouri 63110, United States; Davis, Darryl, Janssen Research and Development, LLC, Spring House, Pennsylvania 19002, United States; Schiel, John, Biomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States / |u http://dx.doi.org/10.1021/bk-2015-1201.ch001 -- |t Sequence Variants and Sequence Variant Analysis in Biotherapeutic Proteins / |r Borisov, Oleg V., Novavax, Inc., Gaithersburg, Maryland 20878, United States; Alvarez, Melissa, Roche Group Member, Genentech, Inc., South San Francisco, California 94080, United States; Carroll, James A., Pfizer Worldwide Research & Development, Chesterfield, Missouri 63017, United States; Brown, Paul W., Pfizer Worldwide Research & Development, Chesterfield, Missouri 63017, United States / |u http://dx.doi.org/10.1021/bk-2015-1201.ch002 -- |t Structural Elucidation of Post-Translational Modifications in Monoclonal Antibodies / |r Li, Wenzhou, Amgen Inc., Thousand Oaks, California 91320, United States; Kerwin, James L., Sanovas Inc., Sausalito, California 94965, United States; Schiel, John, Analytical Chemistry Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States; Formolo, Trina, Analytical Chemistry Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899, United States; Davis, Darryl, Janssen Research and Development, LLC, Spring House, Pennsylvania 19477, United States; Mahan, Andrew, Janssen Research and Development, LLC, Spring House, Pennsylvania 19477, United States; Benchaar, Sabrina A., Amgen Inc., Thousand Oaks, California 91320, United States / |u http://dx.doi.org/10.1021/bk-2015-1201.ch003 -- |t Orthogonal Technologies for NISTmAb N-Glycan Structure Elucidation and Quantitation / |r Prien, Justin M., Analytical Sciences, Amgen Inc., 40 Technology Way, West Greenwich, Rhode Island 02817, United States; Stöckmann, Henning, NIBRT GlycoScience Group, NIBRT (The National Institute for Bioprocessing Research and Training), Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland; Albrecht, Simone, NIBRT GlycoScience Group, NIBRT (The National Institute for Bioprocessing Research and Training), Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland; Martin, Silvia M., NIBRT GlycoScience Group, NIBRT (The National Institute for Bioprocessing Research and Training), Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland; Varatta, Matthew, Analytical Sciences, Amgen Inc., 40 Technology Way, West Greenwich, Rhode Island 02817, United States; Furtado, Marsha, Analytical Sciences, Amgen Inc., 40 Technology Way, West Greenwich, Rhode Island 02817, United States; Hosselet, Stephen, Analytical Sciences, Amgen Inc., 40 Technology Way, West Greenwich, Rhode Island 02817, United States; Wang, Meiyao, Biomolecular Measurement Division, National Institute of Standards and Technology, 100 Bureau Dr., Stop 8314, Gaithersburg, Maryland 20899, United States; Formolo, Trina, Biomolecular Measurement Division, National Institute of Standards and Technology, 100 Bureau Dr., Stop 8314, Gaithersburg, Maryland 20899, United States; Rudd, Pauline M., NIBRT GlycoScience Group, NIBRT (The National Institute for Bioprocessing Research and Training), Fosters Avenue, Mount Merrion, Blackrock, Co. Dublin, Ireland; Schiel, John E., Biomolecular Measurement Division, National Institute of Standards and Technology, 100 Bureau Dr., Stop 8314, Gaithersburg, Maryland 20899, United States / |u http://dx.doi.org/10.1021/bk-2015-1201.ch004 -- |t Separation Methods and Orthogonal Techniques / |r Michels, David A., Department of Protein Analytical Chemistry, Genentech, South San Francisco, California 94080, United States; Ip, Anna Y., Department of Process and Product Development, Amgen Inc., Thousand Oaks, California 91361, United States; Dillon, Thomas M., Department of Process and Product Development, Amgen Inc., Thousand Oaks, California 91361, United States; Brorson, Kurt, Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, United States; Lute, Scott, Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, United States; Chavez, Brittany, Division of Monoclonal Antibodies, Office of Biotechnology Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland 20903, United States; Prentice, Ken M., Department of Process and Product Development, Amgen Inc., Seattle, Washington 98119, United States; Brady, Lowell J., Department of Process and Product Development, Amgen Inc., Seattle, Washington 98119, United States; Miller, Karen J., Global Analytical Sciences, Amgen Inc., Thousand Oaks, California 91320, United States / |u http://dx.doi.org/10.1021/bk-2015-1201.ch005 -- |
| 505 | 0 | 0 | |t Biophysical Techniques for Characterizing the Higher Order Structure and Interactions of Monoclonal Antibodies / |r Gokarn, Yatin, Institute of Chemical Technology, Mumbai, India; Agarwal, Sanjeev, Institute of Chemical Technology, Mumbai, India; Arthur, Kelly, Amgen Inc., Thousand Oaks, California 91320, United States; Bepperling, Alexander, Hexal AG, Oberhaching, Germany; Day, Eric S., Genentech, South San Francisco, California 94080, United States; Filoti, Dana, University of New Hampshire, Durham, New Hampshire 03824, United States; Greene, Daniel G., University of Delaware, Newark, Delaware 19716, United States; Hayes, David, Boehringer Ingelheim, Ridgebury, Connecticut 06877, United States; Kroe-Barrett, Rachel, Boehringer Ingelheim, Ridgebury, Connecticut 06877, United States; Laue, Thomas, University of New Hampshire, Durham, New Hampshire 03824, United States; Lin, Jasper, Genentech, South San Francisco, California 94080, United States; McGarry, Brian, Genentech, South San Francisco, California 94080, United States; Razinkov, Vladimir, Amgen Inc., Thousand Oaks, California 91320, United States; Singh, Sanjaya, Boehringer Ingelheim, Ridgebury, Connecticut 06877, United States; Taing, Rosalynn, Genentech, South San Francisco, California 94080, United States; Venkataramani, Sathyadevi, Boehringer Ingelheim, Ridgebury, Connecticut 06877, United States; Weiss, William, Eli Lilly, Indianapolis, Indiana 46221, United States; Yang, Danlin, Boehringer Ingelheim, Ridgebury, Connecticut 06877, United States; Zarraga, Isidro E., Genentech, South San Francisco, California 94080, United States / |u http://dx.doi.org/10.1021/bk-2015-1201.ch006 -- |t Developability Assessment of a Proposed NIST Monoclonal Antibody / |r Saro, Dorina, Analytical Discovery Group, Biologics Research, Biotechnology Center of Excellence, Janssen Research & Development, LLC, Spring House, Pennsylvania 19477, United States; Baker, Audrey, Analytical Discovery Group, Biologics Research, Biotechnology Center of Excellence, Janssen Research & Development, LLC, Spring House, Pennsylvania 19477, United States; Hepler, Robert, Analytical Discovery Group, Biologics Research, Biotechnology Center of Excellence, Janssen Research & Development, LLC, Spring House, Pennsylvania 19477, United States; Spencer, Stacey, Analytical Discovery Group, Biologics Research, Biotechnology Center of Excellence, Janssen Research & Development, LLC, Spring House, Pennsylvania 19477, United States; Bruce, Rick, Drug Product Development, Parentals and Liquids Formulation, Janssen Research & Development, LLC, Malvern, Pennsylvania 19355, United States; LaBrenz, Steven, Drug Product Development, Parentals and Liquids Formulation, Janssen Research & Development, LLC, Malvern, Pennsylvania 19355, United States; Chiu, Mark, Analytical Discovery Group, Biologics Research, Biotechnology Center of Excellence, Janssen Research & Development, LLC, Spring House, Pennsylvania 19477, United States; Davis, Darryl, Analytical Discovery Group, Biologics Research, Biotechnology Center of Excellence, Janssen Research & Development, LLC, Spring House, Pennsylvania 19477, United States; Lang, Steven E., Analytical Discovery Group, Biologics Research, Biotechnology Center of Excellence, Janssen Research & Development, LLC, Spring House, Pennsylvania 19477, United States / |u http://dx.doi.org/10.1021/bk-2015-1201.ch007 -- |t Protein Particles (0.1 µm to 100 µm) / |r Ripple, Dean C., Biomolecular Measurement Division, National Institute of Standards and Technology, Gaithersburg, Maryland, 20899, United States; Narhi, Linda O., Research and Development, Amgen Inc., Thousand Oaks, California 91320, United States / |u http://dx.doi.org/10.1021/bk-2015-1201.ch008 -- |t Analytical Methods for the Measurement of Host Cell Proteins and Other Process-Related Impurities / |r Prakash, Kesh, Emergent BioSolutions, 300 Professional Drive, Gaithersburg, Maryland 20879, United States; Chen, Weibin, Waters Corporation, 34 Maple Street, Milford, Massachusetts 01757, United States / |u http://dx.doi.org/10.1021/bk-2015-1201.ch009 -- |t Appendix / |u http://dx.doi.org/10.1021/bk-2015-1201.ot002 -- |t Editors' Biographies / |u http://dx.doi.org/10.1021/bk-2015-1201.ot001 |
| 590 | |a American Chemical Society, ACS Symposium Series eBooks - 2015 Front Files. | ||
| 588 | |a Description based on publisher-supplied information and home-page. | ||
| 650 | 0 | |a Immunoglobulins |x Therapeutic use. | |
| 650 | 0 | |a Monoclonal antibodies. |0 http://id.loc.gov/authorities/subjects/sh85005650 | |
| 650 | 0 | |a Monoclonal antibodies |x Structure. | |
| 650 | 0 | |a Sequence alignment (Bioinformatics) |0 http://id.loc.gov/authorities/subjects/sh2008009623 | |
| 650 | 0 | |a Sequential analysis. |0 http://id.loc.gov/authorities/subjects/sh85120148 | |
| 650 | 0 | |a Biological products |x Therapeutic use |x Analysis. | |
| 650 | 0 | |a Monoclonal antibodies |x Modification |x Analysis. | |
| 650 | 0 | |a Orthogonalization methods. |0 http://id.loc.gov/authorities/subjects/sh98004572 | |
| 650 | 0 | |a Separation (Technology) |0 http://id.loc.gov/authorities/subjects/sh85120087 | |
| 650 | 0 | |a Physical biochemistry. |0 http://id.loc.gov/authorities/subjects/sh97008288 | |
| 650 | 0 | |a Proteins |x Molecular aspects |x Measurement. | |
| 650 | 0 | |a Contamination (Technology) |x Analysis. | |
| 650 | 1 | 2 | |a Antibodies, Monoclonal. |
| 650 | 2 | 2 | |a Immunoglobulins |x therapeutic use. |
| 650 | 2 | 2 | |a Sequence Analysis, Protein. |
| 650 | 2 | 2 | |a Biological Therapy. |
| 650 | 2 | 2 | |a Protein Processing, Post-Translational. |
| 650 | 2 | 2 | |a Polysaccharides |x analysis. |
| 650 | 2 | 2 | |a Biophysical Phenomena. |
| 650 | 2 | 2 | |a Proteins |x analysis. |
| 650 | 7 | |a MEDICAL / Microbiology. |2 bisacsh | |
| 650 | 7 | |a MEDICAL / Immunology. |2 bisacsh | |
| 700 | 1 | |a Schiel, John E., |e editor. |u National Institute of Standards and Technology, Gaithersburg, Maryland. |0 http://id.loc.gov/authorities/names/no2009114287 |1 http://viaf.org/viaf/91190637 | |
| 700 | 1 | |a Davis, Darryl L., |e editor. |u Janssen Research and Development, LLC, Spring House, Pennsylvania. |0 http://id.loc.gov/authorities/names/n2014062930 |1 http://viaf.org/viaf/310714992 | |
| 700 | 1 | |a Borisov, Oleg V., |e editor. |u Novavax, Inc., Gaithersburg, Maryland. |1 http://viaf.org/viaf/175703002 | |
| 710 | 2 | |a American Chemical Society, |e sponsoring body. |0 http://id.loc.gov/authorities/names/n78088941 |1 http://viaf.org/viaf/143644441 | |
| 776 | 1 | |c Original |z 9780841230293 (alk. paper) | |
| 776 | 1 | |c Online version |w (OCoLC)892804147 | |
| 830 | 0 | |a ACS symposium series ; |v 1201. |x 1947-5918 | |
| 856 | 4 | 0 | |u https://pubs.acs.org/doi/book/10.1021/bk-2015-1201 |y ACS |
| 903 | |a HeVa | ||
| 929 | |a eresource | ||
| 999 | f | f | |i 5b75b189-46c3-5be0-b251-84c72aaf8344 |s df854ef6-304b-5805-976b-ee23f4992ebf |
| 928 | |t Library of Congress classification |a QR186.85 .S73 2014 |l Online |c UC-FullText |u https://pubs.acs.org/doi/book/10.1021/bk-2015-1201 |z ACS |g ebooks |i 12492699 | ||